Hypothesis

Senescent immune cells actively drive presbyphonia by secreting SASP factors that simultaneously crosslink lamina propria collagen and inhibit thyroarytenoid muscle satellite cell function.

Mechanistic Rationale

• Chronic inflammaging leads to accumulation of senescent CD4+ T cells and macrophages in the laryngeal mucosa (see [1]).
• These cells release IL-6, IL-1β, TNF-α, and MMPs that activate fibroblast mechanotransduction pathways, increasing collagen deposition and reducing hyaluronic acid synthesis ([2], [3]).
• In parallel, SASP factors impair muscle stem cell proliferation via p16^INK4a^‑dependent signaling, lowering the regeneration index after injury ([4], [5]).
• The resulting ECM stiffening alters vocal fold vibration, increasing phonation threshold pressure, which further activates NF‑κB signaling in resident immune cells, creating a feed‑forward loop ([6], [7]).

Novel Insight

We propose that the dominant SASP effector in the vocal fold is not a generic cytokine cocktail but a specific protease‑activated receptor‑1 (PAR‑1) agonist released by senescent γδ T cells. PAR‑1 signaling in fibroblasts drives TGF‑β‑independent collagen cross‑linking via lysyl oxidase‑like 2 (LOXL2) upregulation, while in satellite cells it induces cell‑cycle arrest through SMAD7 upregulation. This dual‑target mechanism explains why anti‑inflammatory broad‑spectrum therapies have limited efficacy in presbyphonia.

Testable Predictions

1. In aged mice, genetic ablation of senescent γδ T cells (using p16^INK4a^-CRE; DTA) will reduce lamina propria LOXL2 expression by >40% and increase hyaluronic acid content measured by ELISA.
2. The same intervention will raise the TA muscle regeneration index from ~0.57 to >0.80 after cardiotoxin injury, comparable to young controls.
3. Pharmacological blockade of PAR‑1 with vorapaxar will mimic the genetic ablation effects, decreasing vocal fundamental frequency shift (ΔF0) by <5% in aged rats during phonation testing.
4. Administering a senolytic that selectively targets CD4+ T cells (e.g., FOXP3‑targeted navitoclax) will not improve ECM parameters, confirming the γδ T‑cell specificity.

Falsifiability

If senescent γδ T‑cell depletion fails to alter LOXL2, HA, or muscle regeneration despite confirmed cell loss, the hypothesis is falsified. Likewise, if PAR‑1 antagonism does not rescue vocal fold biomechanics, the proposed mechanism is incorrect.

References (inline)

[1] https://doi.org/10.1038/s41586-021-03547-7 [2] https://pmc.ncbi.nlm.nih.gov/articles/PMC11253793/ [3] https://doi.org/10.1371/journal.pone.0254710 [4] https://pmc.ncbi.nlm.nih.gov/articles/PMC3522788/ [5] https://doi.org/10.1101/2024.06.20.599817 [6] https://doi.org/10.1007/s11357-022-00572-w [7] https://doi.org/10.1101/gr.240093.118